Degarelix acetate bulk supplier for pharma manufacturers

Degarelix Acetate 120 mg/vial, 80 mg/vial Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 120 mg/vial, 80 mg/vial

Reference Brands: Firmagon (USA, EU)

Degarelix acetate is a gonadotropin-releasing hormone (GnRH) receptor antagonist used in the treatment of advanced prostate cancer. It rapidly reduces testosterone levels without the initial surge seen with LHRH agonists.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Degarelix Acetate — third party manufacturing & bulk supply

Degarelix Acetate 120 mg/vial, 80 mg/vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Degarelix Acetate is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Degarelix Acetate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Degarelix Acetate →

Back to Listing

Frequently Asked Questions

Degarelix acetate is used to treat advanced prostate cancer in men. It works by blocking the action of gonadotropin-releasing hormone (GnRH), leading to a rapid decrease in testosterone levels, which helps slow or stop the growth of prostate cancer cells that depend on testosterone.

Degarelix acetate is made from degarelix, a synthetic decapeptide that acts as a GnRH receptor antagonist. It is formulated as a lyophilized powder that is reconstituted with sterile water before subcutaneous injection. Excipients may include mannitol and other stabilizers.

The most common trade name for Degarelix acetate is Firmagon.

Degarelix acetate (Firmagon) is manufactured by Ferring Pharmaceuticals. Several generic manufacturers also produce it under different brand names in various regions.

The generic name is degarelix acetate.

The brand name is Firmagon.

Degarelix acetate is manufactured by Ferring Pharmaceuticals in Switzerland and other authorized production facilities in Europe. It is also produced by licensed generic manufacturers in India for international export.